Rare Disease Research

Selected news for the healthcare topic - Rare Disease Research, collected since 10/2017. This healthcare topic shares news with Rare Diseases, Pfizer, Seng Cheng and many others.

Please provide a valid email address.
Shares Healthcare News With (link):
Healthcare Topics Rare Diseases, Gene Therapy, Biotech, Clinical Data, Clinical Research, Medical Research, Patient Community, National Institutes of Health, Food and Drug Administration, NIH, Orphan Drugs, Patient Registry
Companies Pfizer, Sangamo Therapeutics, McKesson, Therachon
People Seng Cheng
Locations San Diego, California

Selected Headlines

Date Headline (link) Source Relevant Snippet
9/22/2021 Uplifting Athletes Tackles Funding for Rare Disease Research, Awareness pompediseasenews.com Uplifting Athletes Tackles Funding for Rare Disease Research, Awareness Football and science seem to be disparate fields of play at first glance, but the nonprofit Uplifting Athletes is finding common ground by leveraging the popularity of college gridiron games to fund research for rare diseases. Its nearly two dozen chapters — representing college football teams across the nation — are organizing fundraisers to help young researchers find treatments for the ...
9/22/2021 Uplifting Athletes Tackles Funding for Rare Disease Research, Awareness rettsyndromenews.com Uplifting Athletes Tackles Funding for Rare Disease Research, Awareness Football and science seem to be disparate fields of play at first glance, but the nonprofit Uplifting Athletes is finding common ground by leveraging the popularity of college gridiron games to fund research for rare diseases. Its nearly two dozen chapters — representing college football teams across the nation — are organizing fundraisers to help young researchers find treatments for the ...
9/16/2021 Drug makers failed to block House provision on orphan drug tax credits newsbinding.com WASHINGTON — Drug makers mounted a last-minute, and so far unsuccessful, campaign to kill a surprise provision in House Democrats’ massive spending package that will substantially curtail tax breaks meant to fuel rare disease research , according to an internal industry email obtained by STAT. The provision, which Democrats included in the spending package on Monday, cracks down on the so-called orphan drug tax credit. Currently, drug makers ...
8/25/2021 Morning Headlines 8/25/21 HISTalk ... Raises $20 Million of Growth Equity from Heritage Group Acute care telehealth and teleICU service provider Equum Medical raises $20 million in growth equity. AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research AllStripes, which offers real-world and patient data to support rare disease research , raises $50 million in a Series B funding round ...
8/24/2021 AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research Yahoo News Lux Capital Led Funding, Joined by JAZZ Venture PartnersFinancing to Advance AllStripes’ Capabilities and Launch New Rare Disease Research ProgramsSAN FRANCISCO, August 24, 2021 --( BUSINESS WIRE )-- AllStripes ("Company"), a healthcare technology company dedicated to unlocking treatments for people affected by rare diseases, today announced the Company completed a $50 million Series B financing round.This press release features multimedia. View the full release here: https://www.businesswire.com/news ...
8/24/2021 MBN Media mbn.media ... Dassault Systemes company), McKesson Ventures, and Maveron, along with angel investors including Arif Nathoo, CEO of Komodo Health, and Leila Zegna, Director of the Kabuki Syndrome Foundation. The funding will support launching 100 new rare disease research programs while expanding global operational footprint, technology and data automation enhancements to improve research insights, further developing the platform capabilities to enhance the user experience and strengthen the life sciences offerings, and continuing ...
8/24/2021 AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research | Business Wire Business Wire ... Systèmes company), McKesson Ventures, and Maveron, along with angel investors including Arif Nathoo, CEO of Komodo Health, and Leila Zegna, Director of the Kabuki Syndrome Foundation.The funding will support launching 100 new rare disease research programs while expanding global operational footprint, technology and data automation enhancements to improve research insights, further developing the platform capabilities to enhance the user experience and strengthen the life sciences offerings, and continuing ...
8/24/2021 AllStripes Raises $50M in Series B Financing finsmes.com ... Ventures, and Maveron, along with angel investors including Arif Nathoo, CEO of Komodo Health, and Leila Zegna, Director of the Kabuki Syndrome Foundation. The company intends to use the funds to: - launch 100 new rare disease research programs - expand global operational presence, technology and data automation enhancements to improve research insights, - develop the platform capabilities to enhance the user experience and strengthen the life sciences offerings, and - continue to invest ...
8/24/2021 AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research Business Wire ... Systèmes company), McKesson Ventures, and Maveron, along with angel investors including Arif Nathoo, CEO of Komodo Health, and Leila Zegna, Director of the Kabuki Syndrome Foundation. The funding will support launching 100 new rare disease research programs while expanding global operational footprint, technology and data automation enhancements to improve research insights, further developing the platform capabilities to enhance the user experience and strengthen the life sciences offerings, and continuing ...
8/24/2021 AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research digitalmedianet.com AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research Lux Capital Led Funding, Joined by JAZZ Venture Partners Financing to Advance AllStripes’ Capabilities and Launch New Rare Disease Research Programs SAN FRANCISCO–(BUSINESS WIRE)– healthtech — AllStripes (“Company”), a healthcare technology company dedicated to unlocking treatments for people affected by rare diseases, today announced the Company completed a $50 million Series B ...
8/24/2021 AllStripes Announces $ 50 Million Series B Funding to Advance Global Rare Disease Research bollyinside.com The funding will support launching 100 new rare disease research programs while expanding global operational footprint, technology and data automation enhancements to improve research insights, further developing the platform capabilities to enhance the user experience and strengthen the life sciences offerings, and continuing to invest in growing the company’s team to support creating the playbook for rare disease research. The financing was led by Lux Capital, a current investor ...
8/24/2021 AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research digitalproducer.com AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research Lux Capital Led Funding, Joined by JAZZ Venture Partners Financing to Advance AllStripes’ Capabilities and Launch New Rare Disease Research Programs SAN FRANCISCO–(BUSINESS WIRE)– healthtech — AllStripes (“Company”), a healthcare technology company dedicated to unlocking treatments for people affected by rare diseases, today announced the Company completed a $50 million Series B ...
8/24/2021 AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research tmcnet.com TMCnet News [August 24, 2021] AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research AllStripes ("Company"), a healthcare technology company dedicated to unlocking treatments for people affected by rare diseases, today announced the Company completed a $50 million Series B financing round. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210824005315/en/ Nancy Yu, AllStripes CEO and Co-founder (Photo ...
8/24/2021 AllStripes Secures $50M to Advance Global Rare Disease Research PlatforM HIT Consultant ... by CEO Nancy Yu and technology developer Onno Faber, following his diagnosis and journey with the rare disease neurofibromatosis type 2. AllStripes has developed a technology platform that generates regulatory-ready evidence to accelerate rare disease research and drug development, as well as a patient application that empowers patients and families to securely participate in treatment research online and benefit from their own medical data. – The funding will support ...
8/24/2021 AllStripes Raises $50 Million to Advance Global Rare Disease Research globalgenes.org ... Solutions, McKesson Ventures, Maveron, along with angel investors including Komodo Health CEO Arif Nathoo, and Kabuki Syndrome Foundation Director Leila Zegna. AllStripes has developed a technology platform that generates regulatory-ready evidence to accelerate rare disease research and drug development, as well as a patient application that empowers patients and families to securely participate in treatment research online and benefit from their own medical data. The company was founded by ...
8/24/2021 AllStripes raises $50 million to support rare disease research - MedCity News MedCity News A startup that lets patients share their health records for rare disease research plans to expand its programs with an influx of funding.San Francisco-based AllStripes recently closed a $50 million series B round, led by Lux Capital. It plans to use the capital to launch 100 rare disease research programs, build on its technology and expand its operations to more countries.AllStripes was founded in 2017 by CEO ...
8/24/2021 AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research | Financial Buzz financialbuzz.com ... Systèmes company), McKesson Ventures, and Maveron, along with angel investors including Arif Nathoo, CEO of Komodo Health, and Leila Zegna, Director of the Kabuki Syndrome Foundation.The funding will support launching 100 new rare disease research programs while expanding global operational footprint, technology and data automation enhancements to improve research insights, further developing the platform capabilities to enhance the user experience and strengthen the life sciences offerings, and continuing ...
8/24/2021 AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research vcaonline.com ... and macOS versions. It has been published since 1998. (Updated JULY 2021) Learn More » or Buy Now » AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research Lux Capital Led Funding, Joined by JAZZ Venture Partners Financing to Advance AllStripes’ Capabilities and Launch New Rare Disease Research Programs SAN FRANCISCO, August 24, 2021-- AllStripes (“Company”), a healthcare technology ...
8/24/2021 Big Data to Improve Care for People with Rare Diseases healthnewsdigest.com ... and care options for children with a rare form of epilepsy known as Lennox-Gastaut syndrome. All three studies are funded by the nonprofit Patient-Centered Outcomes Research Institute , or PCORI, which has made rare disease research one of its funding priorities. Rare diseases are often chronically debilitating and sometimes life-threatening. “Treating and caring for people with rare diseases poses many challenges,” said François Modave , Ph.D., an ...
8/23/2021 UF Health researchers use big data to improve care for people with rare diseases | UF Health, University of Florida Health ufhealth.org ... and care options for children with a rare form of epilepsy known as Lennox-Gastaut syndrome. All three studies are funded by the nonprofit Patient-Centered Outcomes Research Institute , or PCORI, which has made rare disease research one of its funding priorities. Rare diseases are often chronically debilitating and sometimes life-threatening. “Treating and caring for people with rare diseases poses many challenges,” said François Modave , Ph.D., an ...